Business Announcement

T Cell Diagnostics has licensed an intellectual property (IP) from Duke-NUS to develop point-of-care assays that could simplify the analysis of T-cell response, enabling better understanding of immune responses.

Innovations from the U of A College of Medicine – Tucson, the Asthma and Airway Disease Research Center and the BIO5 Institute are targeting the deeper causes of asthma and COPD.

Thanks to funding from New York state, Binghamton University, State University of New York will establish an Institute for AI and Society that taps into the power of Empire AI, the most powerful academic research computer in the country.

Adapted Argentine tango dance therapy is helping some breast cancer survivors regain natural balance and sensation after experiencing neuropathy, a common side effect of chemotherapy treatment. Expansion of a new clinical study will look further at how this musical movement intervention can “rewire” the brain to improve function after chemotherapy-related nerve changes. 

The University of Missouri’s transformative initiative to build a new, state-of-the-art research reactor — NextGen MURR — is officially underway with the signing of the first agreement, announced today. Mizzou will partner with a consortium that includes Hyundai Engineering America, the Korea Atomic Energy Research Institute (KAERI), the Hyundai Engineering Company and MPR Associates for the design and licensing of the new reactor.

Cardiology faculty practice is the only heart center in New York to receive the Pinnacle of Excellence Award

The Inter-University Research Institute Corporation Research Organization of Information and Systems, National Institute of Informatics (NII) expanded the bandwidth of all international communication lines connecting Japan, the US, and Europe in the Science Information NETwork SINET6, to 400 Gbps. The upgraded network started operation in April 2025.

An ingestible gas-sensing capsule that provides real-time insights into gut health has moved closer to market with RMIT University transferring IP ownership to medical device company Atmo Biosciences.